Smits, Pieter C <br/><br/>
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).  [electronic resource] 

 -  JACC. Cardiovascular interventions  Aug 2015 
 - 1157-1165 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2015.03.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Agents--administration & dosage<br/>Coronary Artery Disease--diagnosis<br/>Drug-Eluting Stents<br/>Everolimus--administration & dosage<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Metals<br/>Middle Aged<br/>Myocardial Infarction--etiology<br/>Netherlands<br/>Paclitaxel--administration & dosage<br/>Percutaneous Coronary Intervention--adverse effects<br/>Prospective Studies<br/>Prosthesis Design<br/>Risk Factors<br/>Single-Blind Method<br/>Thrombosis--etiology<br/>Time Factors<br/>Treatment Outcome